Further, flow cytometry demonstrated a significant increase in NK1.1+ NK cells within tumor tissues following butyrate treatment, with minimal impact found on the populations of F4/80+ macrophages, CD3+ T lymphocytes, B220+ B lymphocytes, and Ly6G+ neutrophils (Figure 2(d)). The gene discussed is PTPRC; the disease is neoplasm.